TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $910,502 | +16.4% | 58,856 | +18.2% | 0.17% | +17.6% |
| Q2 2023 | $782,327 | +57.8% | 49,798 | +65.5% | 0.15% | +45.1% |
| Q1 2023 | $495,850 | +5.6% | 30,088 | 0.0% | 0.10% | +3.0% |
| Q4 2022 | $469,373 | +20.4% | 30,088 | 0.0% | 0.10% | +2.1% |
| Q3 2022 | $390,000 | -36.7% | 30,088 | -31.5% | 0.10% | -28.1% |
| Q2 2022 | $616,000 | +211.1% | 43,898 | +217.9% | 0.14% | +206.8% |
| Q1 2022 | $198,000 | – | 13,810 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |